financetom
Business
financetom
/
Business
/
Why NuCana (NCNA) Shares Are Trading Lower
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why NuCana (NCNA) Shares Are Trading Lower
Mar 28, 2024 8:54 AM

NuCana plc ( NCNA ) shares are trading lower by 15.2% to $0.26 during Thursday’s session after the company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs) to its ordinary shares from 1:1 to 1:25, effective around April 16. 

This change is akin to a one-for-twenty-five reverse ADS split and aims to enhance liquidity in the company’s ADSs and meet Nasdaq’s minimum bid price requirement. Holders of certificated ADSs must surrender their shares for exchange, while those with uncertificated ADSs need not take action. 

Fractional entitlements will be sold, and proceeds distributed to applicable ADS holders. 

The adjustment is anticipated to result in a proportional increase in ADS trading price, though this outcome cannot be guaranteed.

See Also: Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk’s Weight Loss Sensation Wegovy

How To Buy NCNA Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in NuCana’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, NCNA has a 52-week high of $1.00 and a 52-week low of $0.23.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Orla Shareholders Approve $810-Million Acquisition of the Musselwhite Mine from Newmont
Orla Shareholders Approve $810-Million Acquisition of the Musselwhite Mine from Newmont
Jan 21, 2025
05:17 PM EST, 01/21/2025 (MT Newswires) -- Orla Mining ( ORLA ) on Tuesday said shareholders voted to approve the $810-million acquisition of the Musselwhite gold mine in northwest Ontario from Newmont ( NEM ) . . The company said the vote on the purchase and a concurrent financing was nearly unanimous, with more than 99% of shares voted in...
Ryan Specialty Holdings Insider Sold Shares Worth $7,010,779, According to a Recent SEC Filing
Ryan Specialty Holdings Insider Sold Shares Worth $7,010,779, According to a Recent SEC Filing
Jan 21, 2025
05:15 PM EST, 01/21/2025 (MT Newswires) -- Nicholas Dominic Cortezi, Director, on January 16, 2025, sold 105,000 shares in Ryan Specialty Holdings ( RYAN ) for $7,010,779. Following the Form 4 filing with the SEC, Cortezi has control over a total of 23,606 shares of the company, with 2,697 shares held directly and 20,909 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1849253/000162828025002059/xslF345X05/wk-form4_1737497629.xml ...
Kyverna Therapeutics Names Naji Gehchan as Chief Medical, Development Officer
Kyverna Therapeutics Names Naji Gehchan as Chief Medical, Development Officer
Jan 21, 2025
05:17 PM EST, 01/21/2025 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) said late Tuesday it appointed Naji Gehchan as chief medical and development officer. Gehchan most recently served as the head of clinical development for the imlunestrant breast cancer treatment at Eli Lilly (LLY). Shares of Kyverna Therapeutics ( KYTX ) were up 3% in after-hours trading. ...
Verisk Analytics Insider Sold Shares Worth $595,429, According to a Recent SEC Filing
Verisk Analytics Insider Sold Shares Worth $595,429, According to a Recent SEC Filing
Jan 21, 2025
05:15 PM EST, 01/21/2025 (MT Newswires) -- Kathy Card Beckles, Chief Legal Officer, on January 17, 2025, sold 2,111 shares in Verisk Analytics ( VRSK ) for $595,429. Following the Form 4 filing with the SEC, Beckles has control over a total of 9,066 shares of the company, with 9,066 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1442145/000095017025007377/xslF345X05/ownership.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved